Disposition kinetics of moxifloxacin in lactating ewes

Veterinary Journal

Volumn 178, Issue 2, 2008, Pages 282-287

  Goudah, A ^a  

^a Cairo University   (Egypt)

Author keywords

Ewes; High performance liquid chromatography; Moxifloxacin; Pharmacodynamic; Pharmacokinetic

Indexed keywords

MOXIFLOXACIN;

ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG PENETRATION; DRUG PROTEIN BINDING; EWE; FEMALE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LACTATION; MAMMARY GLAND; MANNHEIMIA HAEMOLYTICA; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STEADY STATE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CROSS-OVER STUDIES; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LACTATION; MILK; QUINOLINES; SHEEP;

ANIMALIA; MANNHEIMIA HAEMOLYTICA;

EID: 54449100914     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.08.007     Document Type: Article

References (40)

1. Abd El-Aty A.M., and Goudah A. Some pharmacokinetic parameters of pefloxacin in lactating goats. Veterinary Research Communications 26 (2002) 553-561
2. Abd El-Aty A.M., Goudah A., Ismail M., and Shimoda M. Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural. Veterinary Research Communications 29 (2005) 297-304
3. Abo El-Sooud K. Influence of albendazole on the disposition kinetics and milk antimicrobial equivalent activity of enrofloxacin in lactating goats. Pharmacological Research 48 (2003) 389-395
4. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62 (2001) 1979-1989
5. Atef M., El-Banna H.A., Abd El-Aty A.M., and Goudah A. Pharmacokinetics of difloxacin in goats. Deutsche Tierärztliche Wochenschrift 109 (2002) 320-323
6. Ball B. Moxifloxacin (Avelox) an 8-methoxyquinolone antibacterial with enhanced potency. International Journal of Clinical Practice 54 (2000) 329-332
7. Baohong J., Sebastein L., Jerome R., Aurelie C., Chantal T., and Vincent J. In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid and PA-824 against Mycobacterium ulcerans. Antimicrobial Agents and Chemotherapy 50 (2006) 1921-1926
8. Blondeau J.M., and Hansen G.T. Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features. Expert Opinion on Pharmacotherapy 2 (2001) 317-335
9. Brogden K.A., Lehmkuhl H.D., and Cutlip R.C. Pasteurella haemolytica complicated respiratory infections in sheep and goats. Veterinary Research 29 (1998) 233-254
10. Brown S.A. Fluorquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19 (1996) 1-14
11. Carceles C.M., Serrano J.M., Marin P., Escudero E., and Fernandez-Varon E. Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration. Journal of Veterinary Medicine A 53 (2006) 300-304
12. Carceles C.M., Villamayor L., Escudero E., Marin P., and Fernandez-Varon E. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. The Veterinary Journal 173 (2007) 452-455
13. Cester C., Schneider M., and Toutain P.L. Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin versus marbofloxacin. Revue de Médecine Vétérinaire 147 (1996) 703-716
14. Craig A.W., and Suh B. Protein binding and the antibacterial effects. Method for determination of protein binding. In: Lorian V. (Ed). Antibiotics in laboratory Medicine (1980), Williams and Wilkins, Baltimore, Maryland 265-297
15. Dalhoff A., Petersen U., and Endermann R. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemotherapy 42 (1996) 410-425
16. Dalla Costa T., and Derendof H. AUIC- a general target for the optimization of dosing regimens of antibiotics. Annals of Pharmacotherapy 30 (1996) 1024-1031
17. Donachie W. Pasteurellosis. In: Martin W.B., and Aitken I.D. (Eds). Diseases of Sheep. third ed. (2000), Blackwell, Oxford 191-198
18. El-Banna H.A., and Abo El-Sooud K. Disposition kinetics of ciprofloxacin in lactating goats. Deutsche Tierärztliche Wochenschrift 105 (1998) 35-38
19. Fernandez-Varon E., Bovaira M.J., Espuny A., Escudero E., Vancraeynest D., and Carceles C.M. Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of Veterinary Pharmacology and Therapeutics 27 (2005) 57-60
20. Fernandez-Varon E., Villamayor L., Escudero E., Espuny A., and Carceles C.M. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. The Veterinary Journal 172 (2006) 302-307
21. Gardner S.Y., Davis J.L., Jones S.L., Lafevers D.H., Hoskins M.S., Mcarver E.M., and Papich M.G. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 57-60
22. Gibaldi M., and Perrier D. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York
23. Hore D.E. A review of respiratory agents associated with disease of sheep, cattle and pigs in Australia and overseas. Australian Veterinary Journal 52 (1976) 502-509
24. Kowalski R.P., Dhaliwal D.K., Karenchak L.M., Romanowski E.G., Mah F.S., Ritterband D.C., and Gordon Y.J. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. American Journal of Ophthalmology 136 (2003) 500-505
25. Martinez M.N. Noncompartmental methods of drug characterization: statistical moment theory. Journal of the American Veterinary Medical Association 213 (1998) 974-980
26. Mavrogianni V.S., and Fthenakis G.C. Efficacy of difloxacin against respiratory infections of lambs. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 325-328
27. NCCLS, 2003. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards M7-A6. Wayne, PA, USA.
28. Shem-Tov M., Ziv G., Glickman A., and Saran A. Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes. Journal of Veterinary Medicine A 44 (1997) 511-519
29. Shem-Tov M., Rav-Hon O., Ziv G., Lavi E., Glickman A., and Saran A. Pharmacokinetics and penetration of danofloxacin from blood into the milk of cows. Journal of Veterinary Pharmacology and Therapeutics 21 (1998) 209-213
30. Siefert H.M., Kohlsdorfer C., Steinke W., and Witt A. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male rats. Journal of Antimicrobial Chemotherapy 43 Suppl. B (1999) 61-67
31. Siefert H.M., Domdey-Bette A., Henninger F., Hucke F., Kohlsdorfer C., Steinke W., and Stass H.H. Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: a comparison in humans and other mammalian species. Journal of Antimicrobial Chemotherapy 43 Suppl. B (1999) 69-76
32. Soback S., Gips M., Bialer M., and Bor A. Effect of lactation on single dose pharmacokinetics of norfloxacin in ewes. Antimicrobial Agents and Chemotherapy 38 (1994) 2336-2339
33. Spreng M., Deleforge J., Thomas E., Boisrame B., and Drugeon H. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 284-289
34. Stass H. Absorption and bioavailability of moxifloxacin. Drugs 58 (1999) 227-228
35. Stass H., and Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. Journal of Antimicrobial Chemotherapy 43 (1999) 83-90
36. Stass H., Dalhoff A., Kubitza D., and Schuhly U. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrobial Agents and Chemotherapy 42 (1998) 2060-2065
37. Toutain P.L., and Bousquet-Melou A. Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 441-453
38. Toutain P.L., Del Castillo J.R.E., and Bousquet-Melou A. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73 (2002) 105-114
39. Waxman S., Rodri{dotless}guez C., Gonzalez F., De Vicente M.L., San Andres M.I., and San Andres M.D. Pharmacokinetics behavior of marbofloxacin after intravenous and intramuscular administration in adult goats. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 375-378
40. Ziv G., Kurtz B., Risenberg R., and Glickman A. Serum and milk concentrations of apramycin in lactating cows, ewes and goats. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 346-351